Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study
HPV vaccination in Australia commenced in 2007, and included vaccination of 12–13 year old girls at school and a catch-up for females aged 12–26 years. The catch-up was delivered through schools, general practices and community-based programs.
•
Women 18–26 years of age vaccinated in the Australian catch-up program have yet to be fully characterized in terms of their socio-demographic, clinical and behavioural profiles.
•
Young adult women vaccinated in the catch-up were more likely to be Australian-born, nulliparous, single and living in higher socioeconomic status areas than unvaccinated women.
•
Vaccinated women had fewer sexual partners but also reported factors associated with potentially increased risk of prior HPV exposure, such as a history of sexually transmitted infections.
•
Although the vaccination catch-up program in Australia has been very effective, the findings reinforce the continuing need to prioritise equitable delivery of vaccination to various population subgroups.
Abstract
Background
Australia commenced a publically-funded, National Human Papillomavirus (HPV) Vaccination Program in 2007 with a two year catch-up phase for females aged 12–26 years.
Objective
To identify the factors associated with the uptake of the HPV vaccine (which has a recommended 3-dose schedule in Australia) by young adult women vaccinated by general practitioners and community-based programs within the catch-up phase.
Methods
1139 women who were eligible to receive the free HPV vaccine during the catch-up period were recruited in 2008–2009 (age 20–29 years at recruitment), in New South Wales, after having a normal (negative) cervical smear result recorded on the NSW Pap Test Register. Participants completed a self-administered questionnaire providing information on vaccination status, and sociodemographic and other factors.
Results
Overall, 880 (77%) women reported receiving ≥1 dose of the vaccine and 777 women (68%) reported receiving ≥2 doses. In multivariable analysis (adjusting for the period for which each woman was eligible for free HPV vaccination), uptake of ≥1 dose of the vaccine was significantly associated with being born in Australia (p < 0.01), being single (p = 0.02), being nulliparous (p < 0.01), living in a higher socioeconomic status area (p-trend = 0.03), living in more remote areas (p = 0.03), drinking alcohol (p < 0.01) and using hormonal contraceptives (p < 0.01). Although vaccinated women were more likely to have fewer sexual partners than unvaccinated women (p-trend = 0.02), they were also more likely to report a prior sexually transmitted infection (STI) (p = 0.03). Similar factors were associated with receiving ≥2 doses.
Conclusions
In this group, women living in higher socioeconomic status areas were more likely to be vaccinated against HPV in the catch-up phase of the national program. Although vaccinated women tended to have fewer sexual partners, they also reported prior STIs, which may be a marker of increased risk of prior exposure to HPV. The findings of this study reinforce the continuing need to prioritise equitable delivery of vaccination to various population subgroups.